Since IGF-2 dysregulation has been already shown in childhood and adult malignancies [33], as well as in benign tumors [34,35,36], it seemed reasonable to investigate the involvement of the IGF-2/IGF-1R pathway in primary pterygium, a benign tumor with premalignant features. The gene discussed is IGF2; the disease is benign neoplasm.